In 2010, Demars et al. demonstrated that APPswe/PS1ΔE9 mice exhibited a significant increase in tau phosphorylation in several brain areas including the hippocampus, likely contributing to the development of the AD phenotype. This evidence concerns the gene MAPT and Alzheimer disease.